EU survey focuses on UDIs to tackle counterfeiting
This article was originally published in RAJ Devices
Executive Summary
Medical device companies and distributors have until 27 July to respond to a European Commission-commissioned survey aimed at assessing the effects of possible actions relating to counterfeiting and developing safer distribution channels for parallel trade1-3. Among other things, the survey focuses on the potential impact of an obligatory unique device identifier system for medical devices.